CSA
GILD icon

Cornerstone Select Advisors’s Gilead Sciences GILD Stock Holding History

Cornerstone Select Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
18,744
+3,140
+20% +$414K 1% 32
2026
Q1 		$2.17M Buy
15,604
+1,270
+9% +$178K 1.36% 25
2025
Q4 		$1.76M Buy
14,334
+1,215
+9% +$148K 1.22% 31
2025
Q3 		$1.46M Buy
13,119
+1,331
+11% +$151K 1.07% 34
2025
Q2 		$1.31M Sell
11,788
-183
-2% -$19.5K 1.15% 34
2025
Q1 		$1.34M Buy
11,971
+1,137
+10% +$117K 1.27% 28
2024
Q4 		$1M Buy
+10,834
New +$975K 0.96% 35

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cornerstone Select Advisors's GILD Position: Q2 2026 in Review

Cornerstone Select Advisors increased its Gilead Sciences (GILD) stake by 20% in Q2 2026, buying an estimated $414K and bringing the position to 18,744 shares worth $2.37M. The position accounts for 1% of the portfolio, ranked #32.

Cornerstone Select Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cornerstone Select Advisors held 18,744 shares of Gilead Sciences worth $2.37M as of Q2 2026.
  • Cornerstone Select Advisors bought 3,140 Gilead Sciences shares in Q2 2026, an estimated $414K.
  • Gilead Sciences made up 1% of Cornerstone Select Advisors's portfolio in Q2 2026, its #32 holding.
  • Cornerstone Select Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cornerstone Select Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.